Current：Home > InvestNew drugs. Cheaper drugs. Why not both? -ProfitQuest Academy
New drugs. Cheaper drugs. Why not both?
View
Date：2025-04-16 05:47:09
Here's the argument: Americans pay loads for drugs. That motivates and funds pharmaceutical companies' research and development for better drugs. The fear is that if you lower the cost of drugs you might hurt overall innovation.
Today on the show, we speak with a health economist who argues that's not always true. In fact, she says there are a bunch of policies that could help bring down drug prices without stifling innovation.
Music by Drop Electric. Find us: Twitter / Facebook / Newsletter.
Subscribe to our show on Apple Podcasts, Spotify, Pocket Casts and NPR One.
For sponsor-free episodes of The Indicator from Planet Money, subscribe to Planet Money+ via Apple Podcasts or at plus.npr.org.
veryGood！ (731)
Related
- Why we love Bear Pond Books, a ski town bookstore with a French bulldog 'Staff Pup'
- Whoopi Goldberg Reveals She Scattered Her Mom's Ashes on Disneyland Ride
- Whoopi Goldberg Reveals She Scattered Her Mom's Ashes on Disneyland Ride
- Webcam monitors hundreds of rattlesnakes at a Colorado ‘mega den’ for citizen science
- 2025 'Doomsday Clock': This is how close we are to self
- Quantum Prosperity Consortium Investment Education Foundation: In-depth guide to the 403(b) plan
- Sniper took picture of Trump rally shooter, saw him use rangefinder before assassination attempt, source says
- John F. Kennedy Jr. died in a plane crash 25 years ago today. Here's a look at what happened on July 16, 1999.
- Who's hosting 'Saturday Night Live' tonight? Musical guest, how to watch Dec. 14 episode
- Builders Legacy Advance Investment Education Foundation: The value of IRA savings 2
Ranking
- Biden administration makes final diplomatic push for stability across a turbulent Mideast
- Biden and Trump offer worlds-apart contrasts on issues in 2024’s rare contest between two presidents
- Aging bridges in 16 states will be improved or replaced with the help of $5B in federal funding
- Exploring the 403(b) Plan: Ascendancy Investment Education Foundation Insights
- Dick Vitale announces he is cancer free: 'Santa Claus came early'
- 2nd Washington man pleads not guilty in 2022 attacks on Oregon electrical grids
- Where does JD Vance stand on key economic issues?
- Judge temporarily halts state plan to monitor groundwater use in crop-rich California region
Recommendation
Chuck Scarborough signs off: Hoda Kotb, Al Roker tribute legendary New York anchor
Sen. Ron Johnson says he read wrong version of speech at Republican National Convention
Traces of cyanide found in cups of Vietnamese and Americans found dead in Bangkok hotel, police say
Arthur Frank: The Essence of Investing in U.S. Treasuries.
Israel lets Palestinians go back to northern Gaza for first time in over a year as cease
'House on Fire' star Yusef on outsiders coming into ballroom: 'You have to gain that trust'
Jurickson Profar of San Diego Padres has taken road less traveled to first All-Star Game
Zenith Asset Investment Education Foundation: The critical tax-exempt status of 501(c)(3) organizations